Management of venous thromboembolism (VTE) in patients with cancer is complex and require the intervention of many specialized health professionals, in hospital but also at home and during follow-up. The AlloTC project aims to integrate the management of VTE within the multidisciplinary care pathway of the patient with cancer, in order to improve the management of VTE in patients with cancer: optimize treatments and follow-up with appropriate anticoagulants, monitor the implementation of good clinical practice, promote patient involvement and adherence. The objective of this monocentric study is to evaluate the efficiency of the integration of the therapeutic management of VTE into a specific management of patient with cancer and to set up a specialized "AlloTC" team that coordinates this course of care. For that purpose, the management of VTE and outcome of patients with cancer and VTE will be compared between two periods : traditional management and management with the "AlloTC" team.
Study Type
OBSERVATIONAL
Enrollment
100
Setting up a specific care path "AlloTC" for management of TVE in patients with cancer with a specific coordination nurse within the "AlloTC" multidisciplinary team as a privileged interlocutor for health professionals and patients with the aim of simplifying the care pathways and ensuring a hospital-city interface organized in collaboration with the attending physician, to develop and publicize tools available for patients and caregivers (information documents, patient monitoring protocols, etc.)
Percentage of patients with appropriate care of venous thromboembolism
Percentage of patients who received appropriate care of venous thromboembolism according to the latest International Good Clinical Practice (GCP) guidelines
Time frame: at 6 months
Percentage of patients with appropriate care of venous thromboembolism
Percentage of patients who received appropriate care of venous thromboembolism according to the latest International Good Clinical Practice (GCP) guidelines
Time frame: at inclusion
Percentage of patients with appropriate care of venous thromboembolism
Percentage of patients who received appropriate care of venous thromboembolism according to the latest International Good Clinical Practice (GCP) guidelines
Time frame: at 3 months
Number of calls from health professionals to the AlloTC team
Time frame: at 6 months
Number of patients lost to follow-up
Time frame: at 3 months
Number of patients lost to follow-up
Time frame: at 6 months
Number of patients evaluated at multidisciplinary meeting
Time frame: at 3 months
Number of patients evaluated at multidisciplinary meeting
Time frame: at 6 months
Number of patients referred to the coordinating nurse in Oncology service
Number of patients referred to the coordinating nurse in Oncology service to reassess the need for supportive care and involve health professionals (dietitian, social worker, psychologist)
Time frame: at 6 months
Number of complications
Recurrence of venous thromboembolism and bleeding episodes.
Time frame: at 3 months
Number of complications
Recurrence of venous thromboembolism and bleeding episodes.
Time frame: at 6 months
Caregiver satisfaction survey concerning on the AlloTC team and care path
Time frame: at inclusion
Caregiver satisfaction survey concerning on the AlloTC team and care path
Time frame: at 3 months
Caregiver satisfaction survey concerning on the AlloTC team and care path
Time frame: at 6 months
Number of patients under care for venous thromboembolism integrated into a personalized care plan as defined in the '' 2009-2013 Cancer Plan ''
Time frame: at 3 months
Number of patients under care for venous thromboembolism integrated into a personalized care plan as defined in the '' 2009-2013 Cancer Plan ''
Time frame: at 6 months
Number of patients accessing the venous thromboembolism information documents.
Time frame: at 6 months
Percentage of patients who had at least 1 session of specialized therapeutic education
Time frame: at 6 months
Assessment of the quality of life of the patient
The quality of life of each patient will be evaluate using the quality of life scale 'EORTC QLC-30'
Time frame: at inclusion
Assessment of the quality of life of the patient
The quality of life of each patient will be evaluate using the quality of life scale 'EORTC QLC-30'
Time frame: at 3 months
Assessment of the quality of life of the patient
The quality of life of each patient will be evaluate using the quality of life scale 'EORTC QLC-30'
Time frame: at 6 months
Patient satisfaction survey concerning the AlloTC team and care path
Time frame: at inclusion
Patient satisfaction survey concerning the AlloTC team and care path
Time frame: at 3 months
Patient satisfaction survey concerning the AlloTC team and care path
Time frame: at 6 months
Number of hospitalizations in the AlloTC cohort
Time frame: at 3 months
Number of hospitalizations in the AlloTC cohort
Time frame: at 6 months
Hospitalization duration in the AlloTC cohort
Time frame: at 3 months
Hospitalization duration in the AlloTC cohort
Time frame: at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.